ESOMEPRAZOLE

ESOMEPRAZOLE was reported 234522 times

ESOMEPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 389 0.6971
1 IMMUNISATION 246 0.5668
2 PALMOPLANTAR KERATODERMA 382 0.5269
3 NEUROLOGIC NEGLECT SYNDROME 257 0.4622
4 SENSITISATION 290 0.3821
5 EJECTION FRACTION 218 0.3752
6 CAROTID ARTERY THROMBOSIS 264 0.3110
7 PRESBYACUSIS 91 0.2955
8 ADJUSTMENT DISORDER 253 0.1946
9 ATRIAL TACHYCARDIA 408 0.1941
10 AMAUROSIS FUGAX 209 0.1941
11 HYPERTENSIVE NEPHROPATHY 199 0.1865
12 POLYCYSTIC OVARIES 278 0.1791
13 POST CHOLECYSTECTOMY SYNDROME 49 0.1731
14 HUMAN RHINOVIRUS TEST POSITIVE 63 0.1689
15 CATARRH 151 0.1670
16 STEROID DEPENDENCE 146 0.1663
17 PRURITUS GENITAL 386 0.1638
18 PNEUMONIA HAEMOPHILUS 62 0.1276
19 NASAL TURBINATE HYPERTROPHY 48 0.1273
20 GRANULOCYTE COUNT INCREASED 50 0.1235
21 PHYSICAL DECONDITIONING 299 0.1161
22 TENOSYNOVITIS STENOSANS 63 0.1131
23 PERSONALITY DISORDER 296 0.1129
24 PLEURAL THICKENING 77 0.1126
25 CAROTID ARTERY OCCLUSION 392 0.1073
26 TENSION HEADACHE 408 0.0948
27 PLEURAL FIBROSIS 95 0.0932
28 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 65 0.0925
29 SLEEP TERROR 384 0.0911
30 BURNS SECOND DEGREE 157 0.0894
31 BLOOD IMMUNOGLOBULIN A INCREASED 48 0.0891
32 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 71 0.0890
33 DIABETIC NEPHROPATHY 193 0.0876
34 GRANULOMA SKIN 67 0.0816
35 NEPHROSCLEROSIS 90 0.0810
36 BLOOD MAGNESIUM INCREASED 73 0.0809
37 ELECTRIC SHOCK 65 0.0758
38 NEPHRECTOMY 110 0.0740
39 EJECTION FRACTION ABNORMAL 89 0.0726
40 RHINITIS ALLERGIC 302 0.0678
41 RHEUMATOID NODULE 186 0.0675
42 BLOOD PRESSURE SYSTOLIC ABNORMAL 166 0.0671
43 CHRONIC KIDNEY DISEASE 5035 0.0662
44 GLOMERULAR FILTRATION RATE INCREASED 53 0.0642
45 VITAMIN B12 INCREASED 51 0.0640
46 END STAGE RENAL DISEASE 1167 0.0639
47 BLOOD PARATHYROID HORMONE DECREASED 89 0.0600
48 OBSTRUCTIVE SLEEP APNOEA SYNDROME 87 0.0596
49 BLOOD PRESSURE DIASTOLIC ABNORMAL 145 0.0570
50 SYSTOLIC DYSFUNCTION 60 0.0569
51 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 60 0.0565
52 MULTI-ORGAN DISORDER 107 0.0543
53 DACTYLITIS 50 0.0509
54 NEPHROGENIC ANAEMIA 235 0.0507
55 URINARY TRACT DISORDER 220 0.0488
56 HYPOPNOEA 167 0.0481
57 HYPOMAGNESAEMIA 659 0.0473
58 RENAL ATROPHY 59 0.0472
59 CAROTID ARTERIOSCLEROSIS 48 0.0465
60 FACIAL PAIN 408 0.0457
61 MAJOR DEPRESSION 320 0.0437
62 RHEUMATOID FACTOR INCREASED 48 0.0430
63 INTERVERTEBRAL DISCITIS 80 0.0424
64 TUBULOINTERSTITIAL NEPHRITIS 795 0.0424
65 NEPHROPATHY 395 0.0423
66 HEMIPLEGIA 351 0.0422
67 SUBARACHNOID HAEMORRHAGE 428 0.0420
68 GASTRIC POLYPS 93 0.0411
69 RENAL INJURY 1214 0.0408
70 ANAEMIA MACROCYTIC 87 0.0407
71 ALCOHOL POISONING 107 0.0399
72 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 71 0.0399
73 PRODUCT USED FOR UNKNOWN INDICATION 50 0.0397
74 VASCULITIS 437 0.0375
75 LOSS OF EMPLOYMENT 111 0.0367
76 HAEMORRHAGIC STROKE 285 0.0365
77 EPIGASTRIC DISCOMFORT 137 0.0350
78 SENSORY LOSS 282 0.0350
79 TENOSYNOVITIS 96 0.0348
80 REBOUND ACID HYPERSECRETION 104 0.0343
81 OSTEOSCLEROSIS 54 0.0343
82 MAST CELL ACTIVATION SYNDROME 48 0.0342
83 GANGRENE 196 0.0325
84 CREPITATIONS 94 0.0315
85 ASPARTATE AMINOTRANSFERASE ABNORMAL 48 0.0315
86 VENTRICULAR TACHYCARDIA 518 0.0313
87 SCLERITIS 50 0.0312
88 RHINITIS 251 0.0311
89 JOINT NOISE 61 0.0310
90 DEAFNESS NEUROSENSORY 102 0.0310
91 ACUTE KIDNEY INJURY 4744 0.0310
92 MOTOR DYSFUNCTION 313 0.0307
93 PANNICULITIS 74 0.0306
94 FEBRILE BONE MARROW APLASIA 128 0.0301
95 AFFECT LABILITY 283 0.0294
96 BRONCHIECTASIS 196 0.0291
97 PERICARDITIS 483 0.0287
98 DIASTOLIC DYSFUNCTION 88 0.0285
99 ANOSMIA 407 0.0281
100 SYNOVIAL CYST 128 0.0277
101 TONGUE BITING 57 0.0276
102 HEPATIC CYTOLYSIS 352 0.0276
103 HYPOCALCAEMIA 519 0.0274
104 VITAMIN B12 DEFICIENCY 111 0.0274
105 DIPLOPIA 710 0.0273
106 CELL DEATH 54 0.0272
107 BLOOD PRESSURE DIASTOLIC DECREASED 198 0.0268
108 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 275 0.0268
109 BREATH SOUNDS ABNORMAL 131 0.0265
110 COORDINATION ABNORMAL 361 0.0259
111 WHITE BLOOD CELLS URINE POSITIVE 48 0.0255
112 BLOOD TEST ABNORMAL 357 0.0254
113 PLEURITIC PAIN 70 0.0253
114 VENTRICULAR HYPOKINESIA 79 0.0246
115 ARTERIAL OCCLUSIVE DISEASE 189 0.0240
116 RENAL CYST 190 0.0239
117 CHOLESTASIS 459 0.0239
118 DRUG TOLERANCE DECREASED 67 0.0238
119 GENERALISED OEDEMA 294 0.0237
120 GINGIVAL PAIN 188 0.0236
121 MUSCLE SPASTICITY 290 0.0236
122 SLEEP APNOEA SYNDROME 443 0.0232
123 MONOCYTE COUNT INCREASED 84 0.0231
124 PAROSMIA 171 0.0226
125 CARPAL TUNNEL SYNDROME 317 0.0226
126 CHRONIC GASTRITIS 51 0.0226
127 SEROTONIN SYNDROME 430 0.0224
128 HYPERPARATHYROIDISM SECONDARY 55 0.0219
129 CARDIAC MURMUR 187 0.0216
130 RED BLOOD CELL SEDIMENTATION RATE INCREASED 236 0.0213
131 MIXED LIVER INJURY 64 0.0212
132 HEPATOCELLULAR INJURY 299 0.0211
133 CHRONIC SINUSITIS 79 0.0210
134 AREFLEXIA 55 0.0206
135 TINNITUS 938 0.0204
136 OCULAR DISCOMFORT 229 0.0204
137 DERMATITIS EXFOLIATIVE GENERALISED 70 0.0201
138 BLOOD PRESSURE SYSTOLIC DECREASED 91 0.0200
139 AZOTAEMIA 79 0.0198
140 HEMIPARESIS 333 0.0196
141 FIBROMYALGIA 474 0.0195
142 GASTROOESOPHAGEAL REFLUX DISEASE 1554 0.0193
143 SINUS CONGESTION 258 0.0191
144 MUSCLE TWITCHING 439 0.0190
145 ANGIOEDEMA 840 0.0190
146 MALNUTRITION 211 0.0188
147 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 317 0.0186
148 TOXIC SKIN ERUPTION 187 0.0185
149 DEMYELINATION 76 0.0185
150 DYSLIPIDAEMIA 94 0.0185
151 GASTROINTESTINAL MOTILITY DISORDER 99 0.0185
152 METABOLIC ACIDOSIS 591 0.0185
153 COLITIS MICROSCOPIC 85 0.0179
154 AGRANULOCYTOSIS 330 0.0177
155 BLOOD PRESSURE SYSTOLIC INCREASED 346 0.0177
156 RESPIRATORY TRACT CONGESTION 275 0.0173
157 ALTERED STATE OF CONSCIOUSNESS 374 0.0172
158 VENTRICULAR ARRHYTHMIA 63 0.0172
159 CUSHINGOID 55 0.0171
160 ANTINUCLEAR ANTIBODY POSITIVE 55 0.0169
161 IRON DEFICIENCY 76 0.0169
162 HYPOKALAEMIA 776 0.0168
163 HYPONATRAEMIA 944 0.0167
164 BLINDNESS 679 0.0166
165 DYSPNOEA AT REST 48 0.0166
166 DIALYSIS 234 0.0165
167 SEDATION 427 0.0163
168 HIATUS HERNIA 211 0.0163
169 HAEMATEMESIS 412 0.0162
170 SKIN NECROSIS 84 0.0162
171 EOSINOPHILIA 282 0.0161
172 PHLEBITIS 82 0.0160
173 SWOLLEN TONGUE 500 0.0160
174 DUODENITIS 49 0.0160
175 NIGHTMARE 552 0.0159
176 ULCER 253 0.0159
177 LEFT VENTRICULAR HYPERTROPHY 68 0.0159
178 TRANSIENT ISCHAEMIC ATTACK 535 0.0158
179 PROTEINURIA 301 0.0158
180 CHOLECYSTITIS ACUTE 89 0.0157
181 RASH MACULO-PAPULAR 349 0.0157
182 RALES 91 0.0157
183 CUTANEOUS VASCULITIS 57 0.0156
184 PHOTOPHOBIA 292 0.0155
185 PANCREATITIS ACUTE 347 0.0154
186 HYPOTHYROIDISM 493 0.0154
187 RASH PAPULAR 345 0.0154
188 CYTOLYTIC HEPATITIS 51 0.0153
189 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 118 0.0152
190 SPINAL OSTEOARTHRITIS 133 0.0151
191 EATING DISORDER 322 0.0151
192 OBSTRUCTIVE AIRWAYS DISORDER 167 0.0150
193 MOUTH HAEMORRHAGE 110 0.0150
194 APHASIA 451 0.0149
195 CEREBRAL HAEMATOMA 50 0.0149
196 HEAD DISCOMFORT 262 0.0148
197 HEPATITIS CHOLESTATIC 89 0.0148
198 RENAL FAILURE 1954 0.0147
199 PAIN OF SKIN 396 0.0147
200 MUSCLE HAEMORRHAGE 59 0.0147
201 HAEMATURIA 503 0.0147
202 THROAT CLEARING 55 0.0147
203 DERMATITIS BULLOUS 106 0.0146
204 FOETAL GROWTH RESTRICTION 89 0.0146
205 SHOCK HAEMORRHAGIC 119 0.0146
206 HYPOPHOSPHATAEMIA 108 0.0146
207 NEPHROLITHIASIS 665 0.0145
208 NEUTROPHIL COUNT INCREASED 148 0.0144
209 MIOSIS 115 0.0143
210 C-REACTIVE PROTEIN INCREASED 520 0.0143
211 LIP SWELLING 475 0.0142
212 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 364 0.0141
213 ATELECTASIS 136 0.0141
214 SKIN HAEMORRHAGE 208 0.0140
215 AORTIC VALVE INCOMPETENCE 59 0.0139
216 BODY TEMPERATURE DECREASED 136 0.0138
217 FULL BLOOD COUNT ABNORMAL 146 0.0138
218 CAROTID ARTERY STENOSIS 48 0.0137
219 VITAMIN D DEFICIENCY 134 0.0137
220 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 659 0.0137
221 RED CELL DISTRIBUTION WIDTH INCREASED 57 0.0137
222 ASTHMATIC CRISIS 50 0.0137
223 IRON DEFICIENCY ANAEMIA 126 0.0136
224 ADRENAL INSUFFICIENCY 165 0.0136
225 IMPAIRED QUALITY OF LIFE 195 0.0136
226 RENAL TUBULAR NECROSIS 133 0.0135
227 GASTRITIS 353 0.0134
228 HYPERKALAEMIA 470 0.0134
229 ANAL ABSCESS 72 0.0133
230 RENAL TRANSPLANT 48 0.0133
231 RESPIRATORY ACIDOSIS 52 0.0132
232 LACTIC ACIDOSIS 427 0.0132
233 IMPAIRED WORK ABILITY 280 0.0131
234 DIVERTICULUM INTESTINAL 57 0.0130
235 ATRIOVENTRICULAR BLOCK COMPLETE 87 0.0130
236 POST-TRAUMATIC STRESS DISORDER 87 0.0130
237 JOINT EFFUSION 89 0.0129
238 DRUG INTERACTION 2045 0.0129
239 NOCTURIA 156 0.0128
240 COGNITIVE DISORDER 600 0.0128
241 ASCITES 377 0.0128
242 RHEUMATOID FACTOR POSITIVE 74 0.0128
243 INTERSTITIAL LUNG DISEASE 620 0.0128
244 BLOOD PRESSURE DIASTOLIC INCREASED 59 0.0128
245 HYPERURICAEMIA 52 0.0126
246 BLOOD URIC ACID INCREASED 73 0.0126
247 FAECALOMA 69 0.0126
248 BLOOD PRESSURE FLUCTUATION 302 0.0126
249 EYE PRURITUS 422 0.0125
250 POLYP 82 0.0125
251 HEPATIC STEATOSIS 233 0.0125
252 GASTRITIS EROSIVE 58 0.0124
253 OSTEOPENIA 188 0.0124
254 TACHYCARDIA 1097 0.0123
255 KIDNEY INFECTION 242 0.0123
256 ANGINA PECTORIS 353 0.0123
257 ENTEROCOLITIS 71 0.0123
258 FOOT DEFORMITY 136 0.0123
259 HYPOALBUMINAEMIA 95 0.0122
260 PRESYNCOPE 296 0.0122
261 ARTHRITIS 956 0.0121
262 HYPERCALCAEMIA 150 0.0121
263 OESOPHAGITIS 131 0.0120
264 CONTRAINDICATED PRODUCT ADMINISTERED 363 0.0120
265 CHOLANGITIS 74 0.0119
266 PYELONEPHRITIS 103 0.0119
267 SINUS DISORDER 235 0.0119
268 COVID-19 PNEUMONIA 140 0.0118
269 BURSITIS 143 0.0118
270 SKIN ULCER 302 0.0117
271 PERICARDIAL EFFUSION 270 0.0117
272 FACIAL PARALYSIS 99 0.0116
273 POLYURIA 95 0.0116
274 SEPTIC SHOCK 503 0.0115
275 TENDERNESS 120 0.0115
276 CYST 142 0.0114
277 HYPERNATRAEMIA 57 0.0114
278 RHABDOMYOLYSIS 477 0.0114
279 ISCHAEMIC STROKE 204 0.0114
280 HYPERCHLORHYDRIA 67 0.0114
281 TOXIC EPIDERMAL NECROLYSIS 172 0.0113
282 DYSARTHRIA 424 0.0113
283 LARGE INTESTINE POLYP 78 0.0112
284 HEPATITIS ACUTE 73 0.0112
285 SNEEZING 251 0.0112
286 DISTURBANCE IN ATTENTION 603 0.0112
287 BLOOD UREA INCREASED 186 0.0111
288 ODYNOPHAGIA 66 0.0110
289 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 91 0.0110
290 RENAL DISORDER 512 0.0110
291 MITRAL VALVE INCOMPETENCE 124 0.0109
292 HYPERLIPIDAEMIA 130 0.0109
293 BLOOD IRON DECREASED 129 0.0109
294 MUSCULAR WEAKNESS 1229 0.0108
295 HAEMOLYTIC ANAEMIA 96 0.0107
296 RESPIRATORY RATE INCREASED 95 0.0107
297 DRUG LEVEL INCREASED 176 0.0106
298 PULMONARY FIBROSIS 201 0.0105
299 BLOOD CREATININE INCREASED 682 0.0104
300 COMA 494 0.0104
301 SPINAL DISORDER 98 0.0103
302 TOXIC ENCEPHALOPATHY 52 0.0103
303 ANURIA 88 0.0102
304 RENAL IMPAIRMENT 859 0.0102
305 GAMMA-GLUTAMYLTRANSFERASE INCREASED 226 0.0102
306 TRICUSPID VALVE INCOMPETENCE 81 0.0102
307 PULMONARY CONGESTION 134 0.0102
308 ACUTE PULMONARY OEDEMA 57 0.0101
309 CYSTITIS 322 0.0101
310 HYPERTHERMIA 77 0.0101
311 MYOPATHY 87 0.0101
312 PURPURA 89 0.0100
313 APHTHOUS ULCER 78 0.0100
314 HEPATITIS 256 0.0100
315 PALPITATIONS 1164 0.0099
316 BASAL CELL CARCINOMA 155 0.0099
317 HYPERTRIGLYCERIDAEMIA 58 0.0099
318 PULMONARY TOXICITY 70 0.0099
319 ELECTROCARDIOGRAM QT PROLONGED 356 0.0099
320 WHEEZING 586 0.0099
321 DRUG-INDUCED LIVER INJURY 310 0.0099
322 HYPERHIDROSIS 1271 0.0099
323 PATHOLOGICAL FRACTURE 50 0.0098
324 MULTIPLE ORGAN DYSFUNCTION SYNDROME 279 0.0098
325 OXYGEN SATURATION DECREASED 553 0.0098
326 INTENTIONAL PRODUCT USE ISSUE 862 0.0098
327 RESPIRATORY DISTRESS 271 0.0098
328 DRUG ERUPTION 174 0.0098
329 ELECTROLYTE IMBALANCE 114 0.0098
330 TEMPERATURE INTOLERANCE 101 0.0098
331 CARDIO-RESPIRATORY ARREST 409 0.0098
332 THYROID DISORDER 150 0.0097
333 POLYARTHRITIS 51 0.0097
334 ACUTE RESPIRATORY FAILURE 186 0.0097
335 SKIN LACERATION 105 0.0096
336 BRADYKINESIA 57 0.0096
337 ANGIOPATHY 54 0.0096
338 HEPARIN-INDUCED THROMBOCYTOPENIA 47 0.0095
339 HALLUCINATION 716 0.0095
340 HYDRONEPHROSIS 71 0.0095
341 NEPHROTIC SYNDROME 65 0.0095
342 RECTAL HAEMORRHAGE 407 0.0095
343 SUDDEN DEATH 100 0.0094
344 ACUTE CORONARY SYNDROME 78 0.0094
345 FLANK PAIN 88 0.0094
346 MELAENA 206 0.0094
347 CORONARY ARTERY STENOSIS 47 0.0093
348 ABDOMINAL PAIN UPPER 1915 0.0093
349 MIGRAINE 883 0.0092
350 OSTEOARTHRITIS 392 0.0092
351 DRUG INTOLERANCE 888 0.0092
352 SYNOVITIS 165 0.0091
353 EYE HAEMORRHAGE 122 0.0091
354 SINUS BRADYCARDIA 88 0.0091
355 DYSPNOEA EXERTIONAL 340 0.0090
356 HEPATIC ENCEPHALOPATHY 84 0.0090
357 DEFORMITY 84 0.0090
358 SUPRAVENTRICULAR TACHYCARDIA 86 0.0090
359 CHOLECYSTITIS 107 0.0090
360 DYSPHAGIA 851 0.0090
361 JAUNDICE 241 0.0089
362 AMNESIA 581 0.0089
363 EMPHYSEMA 90 0.0089
364 INTESTINAL ISCHAEMIA 49 0.0089
365 PERIPHERAL SENSORY NEUROPATHY 52 0.0089
366 CLOSTRIDIUM DIFFICILE COLITIS 94 0.0089
367 CATARACT 526 0.0088
368 BLOOD ALKALINE PHOSPHATASE INCREASED 219 0.0088
369 TROPONIN INCREASED 67 0.0088
370 HYPERBILIRUBINAEMIA 91 0.0088
371 UTERINE LEIOMYOMA 64 0.0087
372 FREQUENT BOWEL MOVEMENTS 234 0.0087
373 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 616 0.0087
374 NERVE INJURY 96 0.0086
375 CARDIOMEGALY 106 0.0086
376 MUSCULOSKELETAL CHEST PAIN 133 0.0086
377 GASTRIC ULCER 163 0.0086
378 BLOOD POTASSIUM INCREASED 139 0.0086
379 LUNG DISORDER 419 0.0085
380 TORSADE DE POINTES 67 0.0085
381 VITAMIN D DECREASED 73 0.0085
382 GASTROINTESTINAL DISORDER 765 0.0085
383 CARDIAC FAILURE 684 0.0085
384 IMPAIRED GASTRIC EMPTYING 116 0.0085
385 DYSURIA 313 0.0085
386 URINE OUTPUT DECREASED 74 0.0085
387 PNEUMONIA ASPIRATION 210 0.0084
388 HAEMODYNAMIC INSTABILITY 64 0.0084
389 INFUSION RELATED REACTION 556 0.0084
390 ALANINE AMINOTRANSFERASE INCREASED 514 0.0084
391 PNEUMOCYSTIS JIROVECII PNEUMONIA 84 0.0084
392 POISONING DELIBERATE 79 0.0083
393 UPPER GASTROINTESTINAL HAEMORRHAGE 140 0.0083
394 POOR VENOUS ACCESS 86 0.0083
395 GASTROENTERITIS 121 0.0083
396 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 79 0.0083
397 CYTOKINE RELEASE SYNDROME 166 0.0083
398 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 62 0.0083
399 SKIN LESION 226 0.0082
400 BLOOD MAGNESIUM DECREASED 71 0.0082
401 HAEMODIALYSIS 69 0.0082
402 OLIGURIA 51 0.0082
403 INFLAMMATION 424 0.0082
404 URINARY INCONTINENCE 243 0.0082
405 ACUTE HEPATIC FAILURE 112 0.0082
406 THERAPEUTIC PRODUCT EFFECT DECREASED 366 0.0082
407 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 53 0.0082
408 CONFUSIONAL STATE 1314 0.0081
409 LIPASE INCREASED 62 0.0081
410 DEHYDRATION 1077 0.0081
411 FACE OEDEMA 136 0.0081
412 ECZEMA 422 0.0081
413 TOOTH INFECTION 106 0.0080
414 SINUS TACHYCARDIA 114 0.0080
415 UPPER-AIRWAY COUGH SYNDROME 66 0.0080
416 ABDOMINAL DISCOMFORT 1342 0.0080
417 LYMPHOCYTE COUNT DECREASED 141 0.0080
418 SUBDURAL HAEMATOMA 114 0.0080
419 ACCIDENTAL OVERDOSE 290 0.0079
420 SYNCOPE 792 0.0079
421 VERTIGO 482 0.0079
422 AFFECTIVE DISORDER 62 0.0079
423 EXOSTOSIS 72 0.0079
424 SUICIDE ATTEMPT 477 0.0079
425 HEART RATE INCREASED 778 0.0078
426 ASPARTATE AMINOTRANSFERASE INCREASED 416 0.0078
427 PULMONARY HYPERTENSION 163 0.0078
428 ORTHOSTATIC HYPOTENSION 136 0.0078
429 SPUTUM DISCOLOURED 74 0.0078
430 SYSTEMIC LUPUS ERYTHEMATOSUS 276 0.0078
431 RED BLOOD CELL COUNT DECREASED 222 0.0078
432 THROMBOCYTOPENIA 867 0.0077
433 ACUTE RESPIRATORY DISTRESS SYNDROME 137 0.0077
434 DIVERTICULUM 55 0.0077
435 HAEMATOMA 200 0.0077
436 PYREXIA 2671 0.0077
437 ANAPHYLACTIC REACTION 426 0.0077
438 ENCEPHALOPATHY 189 0.0077
439 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 68 0.0077
440 PLATELET COUNT INCREASED 100 0.0077
441 INTENTIONAL OVERDOSE 491 0.0076
442 OROPHARYNGEAL DISCOMFORT 69 0.0076
443 ABNORMAL LOSS OF WEIGHT 52 0.0076
444 MICTURITION URGENCY 87 0.0076
445 INTERNATIONAL NORMALISED RATIO INCREASED 217 0.0076
446 RHEUMATOID ARTHRITIS 862 0.0076
447 EYE PAIN 428 0.0076
448 EYELID OEDEMA 88 0.0076
449 RIGHT VENTRICULAR FAILURE 53 0.0076
450 ATRIAL FLUTTER 60 0.0075
451 PANCYTOPENIA 420 0.0075
452 PRESCRIBED UNDERDOSE 149 0.0075
453 MYOCARDIAL ISCHAEMIA 85 0.0075
454 PSEUDOMONAS INFECTION 64 0.0075
455 RESPIRATORY FAILURE 544 0.0075
456 EXTRASYSTOLES 52 0.0074
457 PHOTOSENSITIVITY REACTION 123 0.0074
458 HAEMATOCHEZIA 411 0.0074
459 ABDOMINAL PAIN 1719 0.0074
460 URINARY RETENTION 246 0.0074
461 COUGH 2067 0.0074
462 SEPSIS 814 0.0073
463 ESCHERICHIA INFECTION 60 0.0073
464 UROSEPSIS 67 0.0073
465 PHARYNGEAL SWELLING 71 0.0072
466 DECREASED IMMUNE RESPONSIVENESS 71 0.0072
467 ENCEPHALITIS 50 0.0072
468 CHEST PAIN 1336 0.0072
469 HYPERTENSION 1525 0.0072
470 IMPAIRED HEALING 236 0.0072
471 UPPER RESPIRATORY TRACT INFECTION 332 0.0072
472 CARDIOGENIC SHOCK 103 0.0072
473 LEFT VENTRICULAR DYSFUNCTION 48 0.0072
474 ASTHMA 809 0.0072
475 ACUTE MYOCARDIAL INFARCTION 211 0.0071
476 LOWER RESPIRATORY TRACT INFECTION 325 0.0071
477 BURNING SENSATION 499 0.0071
478 CONJUNCTIVITIS 132 0.0071
479 PRODUCTIVE COUGH 339 0.0071
480 BONE MARROW FAILURE 144 0.0071
481 BLOOD PRESSURE INCREASED 1079 0.0071
482 MUSCLE STRAIN 61 0.0070
483 HUNGER 98 0.0070
484 SINUSITIS 721 0.0070
485 DRY EYE 351 0.0070
486 PEMPHIGOID 53 0.0070
487 RENAL FAILURE ACUTE 298 0.0070
488 DYSPHONIA 410 0.0070
489 HYPOXIA 246 0.0070
490 GENERAL PHYSICAL HEALTH DETERIORATION 808 0.0070
491 TOOTH DISORDER 155 0.0070
492 BLOOD THYROID STIMULATING HORMONE INCREASED 64 0.0069
493 OSTEOPOROSIS 285 0.0069
494 ILEUS 86 0.0069
495 INJECTION SITE EXTRAVASATION 85 0.0069
496 PULMONARY OEDEMA 308 0.0069
497 ANAEMIA 1310 0.0069
498 PERIPHERAL SWELLING 1058 0.0069
499 BODY TEMPERATURE INCREASED 140 0.0069
500 FEBRILE NEUTROPENIA 455 0.0069
501 COVID-19 1200 0.0068
502 MEDICATION ERROR 379 0.0068
503 DYSPEPSIA 670 0.0068
504 DUODENAL ULCER 48 0.0068
505 RHINORRHOEA 439 0.0068
506 WOUND INFECTION 74 0.0068
507 DIABETES MELLITUS INADEQUATE CONTROL 119 0.0067
508 MYOCARDITIS 77 0.0067
509 FALL 2233 0.0067
510 MUCOSAL INFLAMMATION 175 0.0067
511 MUSCULOSKELETAL STIFFNESS 585 0.0067
512 ARTHRALGIA 2765 0.0066
513 SENSATION OF FOREIGN BODY 56 0.0066
514 PLEURAL EFFUSION 403 0.0066
515 HEART RATE DECREASED 232 0.0066
516 RESPIRATORY TRACT INFECTION 172 0.0066
517 SWELLING FACE 429 0.0066
518 DEEP VEIN THROMBOSIS 427 0.0066
519 DELIRIUM 228 0.0066
520 ANAL INCONTINENCE 59 0.0066
521 BLOOD ALBUMIN DECREASED 52 0.0065
522 CHEST DISCOMFORT 671 0.0065
523 LYMPHOPENIA 92 0.0065
524 HEPATIC CIRRHOSIS 122 0.0065
525 JOINT RANGE OF MOTION DECREASED 87 0.0065
526 THROAT IRRITATION 291 0.0065
527 TUMOUR LYSIS SYNDROME 57 0.0065
528 GASTROINTESTINAL INFECTION 58 0.0065
529 COLITIS ULCERATIVE 289 0.0065
530 LEUKOCYTOSIS 117 0.0065
531 DIARRHOEA 4163 0.0064
532 LIVER DISORDER 286 0.0064
533 NASAL CONGESTION 379 0.0064
534 BRONCHITIS 476 0.0064
535 CHOLELITHIASIS 210 0.0064
536 ASPIRATION 70 0.0064
537 HYPOTENSION 1280 0.0064
538 HEPATOTOXICITY 142 0.0064
539 GROIN PAIN 56 0.0064
540 HYPOGLYCAEMIA 308 0.0063
541 ATRIAL FIBRILLATION 618 0.0063
542 HAEMOLYSIS 49 0.0063
543 PULMONARY EMBOLISM 602 0.0063
544 MUSCULOSKELETAL DISCOMFORT 109 0.0063
545 COLITIS 240 0.0063
546 HYPERCHOLESTEROLAEMIA 61 0.0063
547 ERUCTATION 122 0.0063
548 DIVERTICULITIS 174 0.0063
549 INCORRECT PRODUCT ADMINISTRATION DURATION 136 0.0063
550 INTERVERTEBRAL DISC DEGENERATION 58 0.0063
551 PNEUMONITIS 170 0.0062
552 HAEMOPTYSIS 174 0.0062
553 BACK PAIN 1449 0.0062
554 VOMITING 2917 0.0062
555 JOINT SWELLING 745 0.0062
556 DYSPNOEA 3492 0.0062
557 HAEMATOCRIT DECREASED 122 0.0061
558 HEART RATE IRREGULAR 139 0.0061
559 ORAL CANDIDIASIS 81 0.0061
560 LUNG INFILTRATION 54 0.0061
561 WHITE BLOOD CELL COUNT INCREASED 234 0.0061
562 HAEMOGLOBIN DECREASED 624 0.0061
563 BACTERAEMIA 72 0.0061
564 JOINT STIFFNESS 159 0.0061
565 BLOOD LACTATE DEHYDROGENASE INCREASED 96 0.0061
566 PNEUMONIA 1961 0.0061
567 HEADACHE 3797 0.0061
568 HAEMORRHOIDS 118 0.0060
569 GENERALISED TONIC-CLONIC SEIZURE 100 0.0060
570 CANDIDA INFECTION 102 0.0060
571 HELICOBACTER INFECTION 62 0.0060
572 HYPOTHERMIA 61 0.0060
573 SCIATICA 96 0.0060
574 MALAISE 2640 0.0060
575 MYOSITIS 54 0.0060
576 HALLUCINATION, VISUAL 127 0.0060
577 HYPOTONIA 60 0.0060
578 RESPIRATORY DISORDER 179 0.0060
579 RASH PRURITIC 324 0.0060
580 BRADYCARDIA 317 0.0060
581 ANXIETY 1698 0.0060
582 TACHYPNOEA 81 0.0060
583 INFLUENZA 664 0.0059
584 ORAL HERPES 116 0.0059
585 GLOMERULAR FILTRATION RATE DECREASED 73 0.0059
586 MOUTH ULCERATION 125 0.0059
587 CHILLS 695 0.0059
588 SKIN PLAQUE 50 0.0059
589 GASTRIC DISORDER 203 0.0059
590 TENDON RUPTURE 73 0.0059
591 HYPERGLYCAEMIA 215 0.0059
592 NODULE 77 0.0059
593 ERYTHEMA MULTIFORME 55 0.0059
594 EOSINOPHIL COUNT INCREASED 49 0.0059
595 ASTHENIA 2206 0.0059
596 JOINT DISLOCATION 62 0.0059
597 RENAL PAIN 62 0.0058
598 INTENTIONAL PRODUCT MISUSE 512 0.0058
599 ARTERIOSCLEROSIS 55 0.0058
600 PULMONARY MASS 87 0.0058
601 ATAXIA 69 0.0058
602 CYTOPENIA 71 0.0058
603 BODY HEIGHT DECREASED 62 0.0058
604 MYALGIA 984 0.0058
605 CORONARY ARTERY DISEASE 175 0.0058
606 OEDEMA PERIPHERAL 704 0.0058
607 VISUAL IMPAIRMENT 715 0.0058
608 STATUS EPILEPTICUS 65 0.0057
609 HYPERTENSIVE CRISIS 64 0.0057
610 SQUAMOUS CELL CARCINOMA 54 0.0057
611 WEIGHT DECREASED 1599 0.0057
612 SPLENOMEGALY 67 0.0057
613 TRANSAMINASES INCREASED 127 0.0057
614 SHOCK 131 0.0057
615 BLOOD SODIUM DECREASED 107 0.0057
616 MULTI-ORGAN FAILURE 98 0.0057
617 INITIAL INSOMNIA 58 0.0056
618 LIVER INJURY 138 0.0056
619 PANCREATITIS 296 0.0056
620 FAECES DISCOLOURED 121 0.0056
621 BACTERIAL INFECTION 104 0.0056
622 MIDDLE INSOMNIA 104 0.0056
623 NAUSEA 4382 0.0055
624 EPILEPSY 169 0.0055
625 CARDIAC DISORDER 517 0.0055
626 NEPHROPATHY TOXIC 62 0.0055
627 NEUTROPENIA 750 0.0055
628 BLOOD BILIRUBIN INCREASED 149 0.0055
629 HEPATIC FAILURE 166 0.0055
630 CARDIAC FAILURE CONGESTIVE 442 0.0055
631 DECREASED APPETITE 1278 0.0055
632 RESTLESS LEGS SYNDROME 100 0.0055
633 SPINAL PAIN 64 0.0055
634 DIARRHOEA HAEMORRHAGIC 51 0.0055
635 TOOTH FRACTURE 60 0.0054
636 SEASONAL ALLERGY 77 0.0054
637 LEUKOPENIA 272 0.0054
638 HYPERSENSITIVITY 1005 0.0054
639 SOMNOLENCE 1089 0.0054
640 EJECTION FRACTION DECREASED 84 0.0054
641 NEUROPATHY PERIPHERAL 514 0.0054
642 HEPATIC ENZYME INCREASED 368 0.0054
643 RIB FRACTURE 111 0.0054
644 ANAPHYLACTIC SHOCK 139 0.0054
645 DISORIENTATION 213 0.0054
646 SMALL INTESTINAL OBSTRUCTION 66 0.0054
647 LIGAMENT SPRAIN 53 0.0054
648 DRY MOUTH 433 0.0053
649 DEPRESSED MOOD 282 0.0053
650 CHROMATURIA 120 0.0053
651 INSOMNIA 1415 0.0053
652 SALIVARY HYPERSECRETION 53 0.0053
653 TYPE 2 DIABETES MELLITUS 178 0.0053
654 PRURITUS 2028 0.0053
655 STEVENS-JOHNSON SYNDROME 117 0.0053
656 GASTROINTESTINAL HAEMORRHAGE 438 0.0052
657 SPINAL FRACTURE 105 0.0052
658 MEMORY IMPAIRMENT 719 0.0052
659 REBOUND EFFECT 59 0.0052
660 STAPHYLOCOCCAL INFECTION 172 0.0052
661 SLEEP DISORDER 367 0.0052
662 HEAD INJURY 164 0.0052
663 ORAL PAIN 116 0.0052
664 MUSCULOSKELETAL PAIN 270 0.0051
665 ARTHROPATHY 286 0.0051
666 EYE INFECTION 58 0.0051
667 SOPOR 68 0.0051
668 URINARY TRACT INFECTION 875 0.0051
669 LIVER FUNCTION TEST ABNORMAL 149 0.0051
670 PNEUMOTHORAX 81 0.0051
671 VENTRICULAR EXTRASYSTOLES 53 0.0051
672 NECK PAIN 285 0.0051
673 HEPATOMEGALY 50 0.0051
674 CLOSTRIDIUM DIFFICILE INFECTION 111 0.0051
675 CONDITION AGGRAVATED 1545 0.0051
676 BLOOD COUNT ABNORMAL 77 0.0051
677 INTESTINAL OBSTRUCTION 191 0.0051
678 OROPHARYNGEAL PAIN 468 0.0051
679 MUSCLE RIGIDITY 60 0.0050
680 POLYNEUROPATHY 60 0.0050
681 CIRCULATORY COLLAPSE 85 0.0050
682 POLLAKIURIA 208 0.0050
683 ANKLE FRACTURE 77 0.0050
684 BREAST PAIN 53 0.0050
685 INFLUENZA LIKE ILLNESS 408 0.0050
686 LUNG INFECTION 77 0.0050
687 FLATULENCE 281 0.0050
688 PRODUCT PRESCRIBING ERROR 118 0.0049
689 INFECTION 716 0.0049
690 BLOOD CREATINE PHOSPHOKINASE INCREASED 142 0.0049
691 PHARYNGITIS 61 0.0049
692 IRRITABLE BOWEL SYNDROME 105 0.0049
693 PRODUCT USE IN UNAPPROVED INDICATION 1213 0.0049
694 BLOOD CALCIUM DECREASED 55 0.0049
695 FATIGUE 3794 0.0049
696 FOLLICULITIS 51 0.0049
697 MOBILITY DECREASED 348 0.0048
698 ROTATOR CUFF SYNDROME 62 0.0048
699 DERMATITIS CONTACT 55 0.0048
700 ABDOMINAL DISTENSION 502 0.0048
701 UNRESPONSIVE TO STIMULI 124 0.0048
702 DEPRESSED LEVEL OF CONSCIOUSNESS 190 0.0048
703 APHONIA 67 0.0048
704 PAIN 2945 0.0048
705 PETECHIAE 50 0.0048
706 NEURALGIA 116 0.0048
707 GLYCOSYLATED HAEMOGLOBIN INCREASED 120 0.0047
708 TREATMENT FAILURE 392 0.0047
709 DYSGEUSIA 351 0.0047
710 MASS 66 0.0047
711 HYPERTHYROIDISM 68 0.0047
712 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 245 0.0047
713 CYTOMEGALOVIRUS INFECTION 78 0.0047
714 GASTRIC HAEMORRHAGE 54 0.0047
715 DEVICE RELATED INFECTION 72 0.0047
716 BRAIN OEDEMA 59 0.0047
717 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 80 0.0047
718 CELLULITIS 235 0.0047
719 OEDEMA 252 0.0046
720 MYOCLONUS 55 0.0046
721 DIZZINESS 2294 0.0046
722 FEEDING DISORDER 93 0.0046
723 HEPATIC FUNCTION ABNORMAL 171 0.0046
724 HYPOPHAGIA 117 0.0046
725 CEREBROVASCULAR ACCIDENT 775 0.0046
726 INTERVERTEBRAL DISC PROTRUSION 100 0.0046
727 METASTASES TO LIVER 80 0.0045
728 PAIN IN EXTREMITY 1336 0.0045
729 DRY SKIN 604 0.0045
730 BALANCE DISORDER 390 0.0045
731 BLOOD PRESSURE DECREASED 298 0.0045
732 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 246 0.0045
733 LYMPHOMA 69 0.0045
734 DEPRESSION 1014 0.0045
735 ALOPECIA 875 0.0045
736 PAIN IN JAW 126 0.0044
737 CEREBRAL HAEMORRHAGE 159 0.0044
738 FOOT FRACTURE 84 0.0044
739 DISCOMFORT 270 0.0044
740 HAND DEFORMITY 58 0.0044
741 MUSCLE ATROPHY 56 0.0044
742 BACK INJURY 48 0.0044
743 CHOKING 86 0.0044
744 MYOCARDIAL INFARCTION 768 0.0044
745 BLOOD POTASSIUM DECREASED 132 0.0044
746 GASTROENTERITIS VIRAL 79 0.0044
747 EAR PAIN 85 0.0044
748 STOMATITIS 265 0.0044
749 LIMB DISCOMFORT 135 0.0044
750 ECONOMIC PROBLEM 66 0.0044
751 PULMONARY ARTERIAL HYPERTENSION 63 0.0043
752 HALLUCINATION, AUDITORY 69 0.0043
753 BONE DENSITY DECREASED 136 0.0043
754 NASOPHARYNGITIS 795 0.0043
755 RASH 1877 0.0043
756 CORONARY ARTERY OCCLUSION 59 0.0043
757 FUNGAL INFECTION 143 0.0043
758 INFUSION SITE PAIN 55 0.0043
759 GLAUCOMA 82 0.0043
760 FLUID RETENTION 216 0.0042
761 RASH ERYTHEMATOUS 203 0.0042
762 INJECTION SITE IRRITATION 54 0.0042
763 LOSS OF CONSCIOUSNESS 542 0.0042
764 POOR QUALITY SLEEP 91 0.0042
765 BLOOD CHOLESTEROL INCREASED 197 0.0042
766 NEUTROPHIL COUNT DECREASED 172 0.0042
767 OBESITY 67 0.0042
768 CONSTIPATION 917 0.0042
769 ARRHYTHMIA 199 0.0042
770 COAGULOPATHY 70 0.0042
771 TENDONITIS 65 0.0042
772 FEELING ABNORMAL 1005 0.0042
773 SWELLING 392 0.0042
774 DISEASE RECURRENCE 199 0.0042
775 JOINT INJURY 89 0.0042
776 VISION BLURRED 572 0.0042
777 PALLOR 113 0.0041
778 SECRETION DISCHARGE 52 0.0041
779 TASTE DISORDER 84 0.0041
780 OFF LABEL USE 3616 0.0041
781 ERECTILE DYSFUNCTION 106 0.0041
782 ADVERSE DRUG REACTION 370 0.0041
783 SKIN EXFOLIATION 347 0.0041
784 FEELING HOT 252 0.0041
785 ANHEDONIA 108 0.0041
786 HERPES ZOSTER 236 0.0041
787 IMMUNODEFICIENCY 61 0.0041
788 MOVEMENT DISORDER 131 0.0041
789 DIABETES MELLITUS 310 0.0041
790 CEREBRAL INFARCTION 99 0.0040
791 APATHY 59 0.0040
792 GAIT INABILITY 135 0.0040
793 VIRAL INFECTION 134 0.0040
794 BLOOD TRIGLYCERIDES INCREASED 71 0.0040
795 MYELODYSPLASTIC SYNDROME 58 0.0040
796 FEELING JITTERY 76 0.0040
797 ERYTHEMA 819 0.0040
798 HERNIA 77 0.0040
799 DEAFNESS 104 0.0040
800 RASH MACULAR 139 0.0040
801 BLOOD GLUCOSE INCREASED 747 0.0040
802 LETHARGY 228 0.0040
803 TOXICITY TO VARIOUS AGENTS 668 0.0040
804 ABDOMINAL PAIN LOWER 100 0.0040
805 ABSCESS 63 0.0039
806 LIMB INJURY 107 0.0039
807 WOUND 110 0.0039
808 BRONCHOSPASM 56 0.0039
809 PLATELET COUNT DECREASED 416 0.0039
810 PARAESTHESIA 611 0.0039
811 LYMPHADENOPATHY 137 0.0039
812 SKIN DISORDER 129 0.0039
813 COLD SWEAT 68 0.0039
814 LOCALISED INFECTION 93 0.0038
815 CYANOSIS 60 0.0038
816 FEMUR FRACTURE 118 0.0038
817 BONE PAIN 222 0.0038
818 NIGHT SWEATS 122 0.0038
819 RESTLESSNESS 138 0.0038
820 PRODUCT SUBSTITUTION ISSUE 217 0.0038
821 HOT FLUSH 282 0.0037
822 BLOOD URINE PRESENT 71 0.0037
823 CARDIAC ARREST 308 0.0037
824 PSORIASIS 485 0.0037
825 CONTUSION 357 0.0037
826 RETCHING 79 0.0037
827 FRACTURE 70 0.0037
828 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 666 0.0037
829 DISSEMINATED INTRAVASCULAR COAGULATION 52 0.0037
830 INTENTIONAL SELF-INJURY 74 0.0037
831 METASTASES TO BONE 60 0.0037
832 DEMENTIA 101 0.0036
833 SENSORY DISTURBANCE 58 0.0036
834 MUSCLE SPASMS 662 0.0036
835 TREMOR 598 0.0036
836 THERAPEUTIC RESPONSE DECREASED 218 0.0036
837 HIP FRACTURE 115 0.0036
838 GLOSSODYNIA 80 0.0036
839 BLOOD PRESSURE ABNORMAL 71 0.0036
840 PERIPHERAL COLDNESS 49 0.0036
841 WEIGHT INCREASED 799 0.0036
842 BONE DISORDER 65 0.0036
843 HAEMORRHAGE INTRACRANIAL 53 0.0035
844 THERAPY PARTIAL RESPONDER 55 0.0035
845 CARDIOMYOPATHY 52 0.0035
846 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 82 0.0035
847 WHITE BLOOD CELL COUNT DECREASED 380 0.0035
848 FLUID OVERLOAD 51 0.0035
849 HYPOAESTHESIA 523 0.0035
850 THERAPY NON-RESPONDER 157 0.0035
851 URTICARIA 584 0.0035
852 EAR INFECTION 92 0.0035
853 EPISTAXIS 258 0.0034
854 PHARYNGEAL OEDEMA 53 0.0034
855 AGITATION 253 0.0034
856 PRODUCT USE ISSUE 646 0.0034
857 DELUSION 53 0.0034
858 SKIN REACTION 48 0.0034
859 MENTAL STATUS CHANGES 94 0.0034
860 PSORIATIC ARTHROPATHY 136 0.0033
861 GAIT DISTURBANCE 641 0.0033
862 TOOTHACHE 60 0.0033
863 THROMBOSIS 265 0.0033
864 PERITONITIS 68 0.0033
865 DYSSTASIA 95 0.0033
866 DYSKINESIA 132 0.0032
867 THIRST 58 0.0032
868 DRUG EFFECT LESS THAN EXPECTED 48 0.0032
869 MULTIPLE FRACTURES 53 0.0032
870 GASTRIC CANCER 81 0.0032
871 POST PROCEDURAL COMPLICATION 60 0.0031
872 GOUT 56 0.0031
873 THROAT TIGHTNESS 84 0.0031
874 BLISTER 174 0.0031
875 PELVIC PAIN 56 0.0031
876 EYE IRRITATION 177 0.0031
877 HAEMORRHAGE 317 0.0030
878 PREMATURE BABY 91 0.0030
879 BACK DISORDER 49 0.0030
880 SEIZURE 348 0.0030
881 FEAR 81 0.0030
882 SKIN DISCOLOURATION 138 0.0030
883 INJECTION SITE REACTION 205 0.0030
884 DISEASE PROGRESSION 352 0.0030
885 FLUSHING 302 0.0030
886 SKIN FISSURES 58 0.0030
887 ILL-DEFINED DISORDER 180 0.0030
888 DIABETIC KETOACIDOSIS 71 0.0030
889 SUICIDAL IDEATION 270 0.0029
890 MUSCULOSKELETAL DISORDER 56 0.0029
891 OSTEONECROSIS 96 0.0029
892 UPPER LIMB FRACTURE 58 0.0029
893 MULTIPLE SCLEROSIS 139 0.0029
894 RESPIRATORY ARREST 80 0.0029
895 PRODUCT AVAILABILITY ISSUE 66 0.0029
896 SPEECH DISORDER 150 0.0029
897 INCREASED APPETITE 54 0.0028
898 BLOOD GLUCOSE ABNORMAL 52 0.0028
899 RASH GENERALISED 72 0.0028
900 DRUG INEFFECTIVE 3633 0.0028
901 ILLNESS 283 0.0027
902 MALIGNANT NEOPLASM PROGRESSION 280 0.0027
903 MENTAL DISORDER 118 0.0027
904 HOSPITALISATION 415 0.0027
905 DERMATITIS 56 0.0027
906 INTENTIONAL DOSE OMISSION 76 0.0027
907 PANIC ATTACK 97 0.0027
908 OCULAR HYPERAEMIA 126 0.0027
909 LIVER FUNCTION TEST INCREASED 57 0.0027
910 FEELING COLD 72 0.0026
911 FOETAL EXPOSURE DURING PREGNANCY 210 0.0026
912 PROCEDURAL PAIN 71 0.0026
913 NEOPLASM PROGRESSION 88 0.0025
914 AGEUSIA 62 0.0025
915 PRESCRIBED OVERDOSE 48 0.0025
916 OVERDOSE 535 0.0025
917 CARDIOVASCULAR DISORDER 62 0.0024
918 BLOOD GLUCOSE DECREASED 117 0.0024
919 OSTEONECROSIS OF JAW 60 0.0024
920 TREATMENT NONCOMPLIANCE 132 0.0024
921 PRURITUS GENERALISED 52 0.0024
922 MATERNAL EXPOSURE DURING PREGNANCY 213 0.0024
923 THERAPEUTIC RESPONSE SHORTENED 79 0.0024
924 HYPERSOMNIA 68 0.0024
925 MOOD ALTERED 64 0.0023
926 CRYING 85 0.0023
927 COMPLETED SUICIDE 193 0.0023
928 ADVERSE EVENT 213 0.0023
929 IRRITABILITY 137 0.0023
930 PRODUCT PRESCRIBING ISSUE 49 0.0022
931 EYE SWELLING 83 0.0022
932 PLASMA CELL MYELOMA 87 0.0022
933 ROAD TRAFFIC ACCIDENT 93 0.0022
934 MENTAL IMPAIRMENT 53 0.0022
935 PRODUCT DOSE OMISSION IN ERROR 61 0.0022
936 DRUG ABUSE 178 0.0021
937 NEEDLE ISSUE 62 0.0021
938 NEOPLASM MALIGNANT 142 0.0021
939 LACRIMATION INCREASED 63 0.0021
940 INJECTION SITE MASS 77 0.0021
941 INCORRECT DOSE ADMINISTERED 460 0.0020
942 PSYCHOTIC DISORDER 59 0.0020
943 MOOD SWINGS 63 0.0020
944 AGGRESSION 97 0.0019
945 ABNORMAL BEHAVIOUR 76 0.0019
946 NERVOUSNESS 100 0.0019
947 HYPOACUSIS 82 0.0019
948 SURGERY 109 0.0019
949 NERVOUS SYSTEM DISORDER 58 0.0019
950 UNEVALUABLE EVENT 139 0.0018
951 PRODUCT DOSE OMISSION ISSUE 534 0.0018
952 ABNORMAL DREAMS 50 0.0018
953 UNDERDOSE 132 0.0018
954 ANGER 61 0.0018
955 EMOTIONAL DISTRESS 210 0.0017
956 LABORATORY TEST ABNORMAL 49 0.0017
957 EYE DISORDER 54 0.0016
958 LUNG NEOPLASM MALIGNANT 67 0.0016
959 EXPOSURE DURING PREGNANCY 98 0.0016
960 PRODUCT DOSE OMISSION 102 0.0016
961 VISUAL ACUITY REDUCED 51 0.0015
962 MYELOSUPPRESSION 55 0.0015
963 THERAPY INTERRUPTED 108 0.0015
964 ACNE 114 0.0015
965 DEATH 1277 0.0015
966 INJECTION SITE PRURITUS 99 0.0015
967 INJECTION SITE ERYTHEMA 182 0.0015
968 INJURY 101 0.0014
969 WITHDRAWAL SYNDROME 59 0.0014
970 THERAPEUTIC RESPONSE UNEXPECTED 63 0.0014
971 VAGINAL HAEMORRHAGE 60 0.0014
972 CONVULSION 78 0.0014
973 INJECTION SITE PAIN 414 0.0013
974 INJECTION SITE BRUISING 105 0.0013
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 266 0.0013
976 THERAPY CESSATION 63 0.0012
977 DEVICE ISSUE 110 0.0012
978 RENAL CANCER 58 0.0012
979 DEVICE BREAKAGE 49 0.0012
980 DEVICE DISLOCATION 51 0.0012
981 BREAST CANCER 109 0.0012
982 INJECTION SITE SWELLING 85 0.0011
983 PRODUCT QUALITY ISSUE 150 0.0011
984 DRUG EFFECT DECREASED 59 0.0011
985 SKIN BURNING SENSATION 73 0.0010
986 MULTIPLE SCLEROSIS RELAPSE 66 0.0010
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 67 0.0009
988 INJECTION SITE HAEMORRHAGE 75 0.0009
989 DEVICE MALFUNCTION 50 0.0007
990 ACCIDENTAL EXPOSURE TO PRODUCT 73 0.0007
991 DRUG DOSE OMISSION 101 0.0006
992 DRUG DEPENDENCE 89 0.0006
993 DRUG WITHDRAWAL SYNDROME 48 0.0005
994 NO ADVERSE EVENT 90 0.0005